We recently reported the main findings of the REmission Studies Evaluating Type 2 Diabetes - Intermittent Insulin Therapy Main (RESET-IT Main) trial, which demonstrated that the addition of intermittent courses of IIT does not further enhance the beneficial effect on beta-cell function achieved with initial induction IIT followed by metformin maintenance11. The gene discussed is INS; the disease is type 2 diabetes mellitus.